Stock List

Search by Ticker



Danaher Corporation (NYSE:DHR)
Stock Analysis

▲ 0.07%0.15

Stock Analysis

The following stock analysis is based on 7.8 years of data (i.e. since Oct 31, 2012). All the stock history has been downloaded.

Stock Exchange

Danaher Corporation trades on the NYSE exchange in USD dollars.


It is in the healthcare sector.

Current Status of Danaher Corporation

It is currently trading at $205.69 ($205.54 the previous day).It pays a 0.34% dividend.


The next reporting date is in 69 days (2020 10 15).

CNN estimates profits for the upcoming quarter will be $1.35 per share ($5.5B). The current Canada / US exchange rate is 1.3347.

Over the past 12 months, $23839723 worth of shares have been purchased and $162854444 worth of shares have been sold by insiders.

Will This Trend Continue?

The year over year average increase is 24.6% per year assuming steady exponential growth. The actual 5 year average is 19.22. Details on the individual increase in one year intervals is provided below.

Past PerformanceAverage PricePercent Change
1 year151.0658951219528.5+ Above Average
2 year117.5339222.6+ Above Average
3 year95.84866108786617.1- Below Average
4 year81.82561475409814.5- Below Average
5 year71.43833333333313.4- Below Average
Danaher Corporation is projected by analysts to get to $219.00 within the next 12 months (6.5%), but preticted targets range from as high as $235.00 (14.2%) and as low as $178(-13.5%).


The worst drop it has had in recent years is -26.9%. It has a shape to the stock curve, which means

Stock shape test


With an average increase of 24.6% year over year, if Danaher Corporation is bought at the worst time, Stockmarketizer analysts estimate it will take 13.1 months before the stock will recover to the original purchase price. The P/E value is 43.93. The stock is under valued as the industry standard in the healthcare sector is a P/E of 86.26.

Tradingview BuySell Widget

Yahoo News Feed

GE Competitor Siemens Healthineers Makes Blockbuster Acquisition

Sun, 02 Aug 2020 14:53:00 Siemens Healthineers is buying Varian Medical Systems in a $16 billion merger, marrying health-care diagnostics with therapies.... Read Full Article

Vanguard Health Care Fund Adds 3 Stocks to Portfolio

Fri, 31 Jul 2020 16:58:36 Fund focused on health reveals 2nd-quarter trades Continue reading...... Read Full Article

3 Zacks Rank #1s Making New Highs

Fri, 31 Jul 2020 16:25:04 3 Zacks Rank 1s Making New Highs... Read Full Article

Should You Buy Danaher Stock at Its All-Time High?

Thu, 30 Jul 2020 13:50:00 The healthcare-focused company continues to power higher. Hereand's whatand's driving it, and why the stock can continue to appreciate.... Read Full Article

Earnings Estimates Rising for Danaher (DHR): Will It Gain?

Wed, 29 Jul 2020 16:20:04 Danaher (DHR) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.... Read Full Article

Hereand's Why Danaher (DHR) is a Great Momentum Stock to Buy

Tue, 28 Jul 2020 16:00:04 Does Danaher (DHR) have what it takes to be a top stock pick for momentum investors? Letand's find out.... Read Full Article

INSIGHT-The U.S. has more COVID-19 testing than most. So why is it falling so short?

Mon, 27 Jul 2020 11:00:00 The United States might have more COVID-19 testing capacity than any other country. At the heart of the crisis is a reliance by public and private labs on automated testing equipment that locks them in to using proprietary chemical kits ...... Read Full Article

Covid Report: Why These Health Stocks Diverged On Strong Testing Sales

Thu, 23 Jul 2020 20:06:07 Revenue from coronavirus tests helped bolster Roche and Danaherand's second quarters, but the health care stocks diverged Thursday. Roche also reported a big decline in pharmaceutical sales.... Read Full Article

Danaher Corp (DHR) Q2 2020 Earnings Call Transcript

Thu, 23 Jul 2020 19:00:55 DHR earnings call for the period ending July 3, 2020.... Read Full Article

Danaher (DHR) Beats on Q2 Earnings, Gives Impressive View

Thu, 23 Jul 2020 16:13:04 Danaherand's (DHR) Q2 results gain from contribution from Cytiva and suffer from forex woes. Core sales in Q3 are expected to grow primarily on gains from Cytiva.... Read Full Article

The Zacks Analyst Blog Highlights: CoreLogic, AutoNation, Danaher and NextEra Energy

Thu, 23 Jul 2020 12:59:12 The Zacks Analyst Blog Highlights: CoreLogic, AutoNation, Danaher and NextEra Energy... Read Full Article

Beckman Coulterand's Automated Blood Banking Analyzer Receives 510(k) FDA Clearance

Thu, 23 Jul 2020 12:00:00 Beckman Coulter today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its PK7400 Automated Microplate System and the systemand's reagents have completed FDA approval. Designed for use in blood donor and ...... Read Full Article

Danaher (DHR) Q2 Earnings and Revenues Surpass Estimates

Thu, 23 Jul 2020 11:30:11 Danaher (DHR) delivered earnings and revenue surprises of 35.85% and 6.74%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?... Read Full Article

Danaher: Q2 Earnings Insights

Thu, 23 Jul 2020 11:10:47 Shares of Danaher (NYSE:DHR) moved higher by 2.1% in pre-market trading after the company reported Q2 results.Quarterly Results Earnings per share were up 21.01% year over year to $1.44, which beat the estimate of $1.08.Revenue of $5,297,000,000 higher by 2.71% year over year, ...... Read Full Article

Danaher Reports Second Quarter 2020 Results

Thu, 23 Jul 2020 10:00:00 Danaher Corporation (NYSE: DHR) (the and"Companyand") today announced results for the quarter ended July 3, 2020. All results in this release reflect only continuing operations unless otherwise noted.... Read Full Article

Beckman Coulter Wins SelectScience Awards for Best New Clinical Instrumentation and Customer Service of the Year

Tue, 21 Jul 2020 20:52:00 Beckman Coulter, a global leader in clinical diagnostics, announced today that it received the Scientistsand' Choice Award® for Best New Clinical Laboratory Instrumentation of 2019 for its DxA 5000 Total Laboratory Automation System, as well as the Reviewerand's Choice Award for Clinical ...... Read Full Article

Danaher (DHR) Upgraded to Buy: What Does It Mean for the Stock?

Tue, 21 Jul 2020 16:00:04 Danaher (DHR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 2 (Buy).... Read Full Article

Will Danaher (DHR) Keep Its Earnings Streak Alive in Q2?

Tue, 21 Jul 2020 13:20:01 Danaherand's (DHR) Q2 results are anticipated to reflect healthy demand for some of its products and synergistic gains from Cytiva. Yet, subdued demand for a few other products is expected to have ailed.... Read Full Article

Tesla, ATandT, Microsoft, Intel, and Other Stocks for Investors to Watch This Week

Sun, 19 Jul 2020 19:00:00 Second-quarter earnings season continues with results from Tesla, Microsoft, Chipotle, IBM, United Airlines, ATandT, Twitter, Verizon, Intel, and more. Plus, a Senate vote on Fed governors.... Read Full Article

In a Socially Distanced World, Marathons Get Creative. Here’s New York’s Plan.

Sat, 18 Jul 2020 00:50:00 The New York City Marathon race will take place between Oct. 17 and Nov. 1, with runners taking to their local streets, instead of the traditional 26.2 mile course across the city’s five boroughs.... Read Full Article